Efficacy and Safety of Lemborexant in Elderly Subjects with Insomnia Disorder: Pooled Analyses from SUNRISE-1 and SUNRISE-2

被引：0
|
作者：
Moline, Margaret [1 ]
Yardley, Jane [2 ]
Pinner, Kate [2 ]
Kumar, Dinesh [1 ]
Bsharat, Mohammed [1 ]
Karppa, Mikko [3 ,4 ]
Zammit, Gary [5 ]
Perdomo, Carlos [1 ]
Mianulli, Caroline [6 ]
Rosenberg, Russell [6 ]
机构：
[1] Eisai Inc, Tokyo, Japan
[2] Eisai Ltd, Tokyo, Japan
[3] Oulu Univ Hosp, Oulu, Finland
[4] Univ Oulu, Oulu, Finland
[5] Clinilabs Drug Dev Corp, Eatontown, NJ USA
[6] NeuroTrials Res Inc, Atlanta, GA USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1860
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies
    Uchiyama, Makoto
    Mishima, Kazuo
    Yagi, Tomoko
    Yoshihara, Tatsuya
    Eto, Takashi
    Muehlan, Clemens
    Togo, Osamu
    Inoue, Yuichi
    [J]. JOURNAL OF SLEEP RESEARCH, 2024,
  • [22] Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial
    Ivgy-May, Neely
    Roth, Thomas
    Ruwe, Frank
    Walsh, James
    [J]. SLEEP MEDICINE, 2015, 16 (07) : 831 - 837
  • [23] Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer’s Disease Dementia: Results From a Phase 2 Randomized Clinical Trial
    Margaret Moline
    S. Thein
    M. Bsharat
    N. Rabbee
    M. Kemethofer-Waliczky
    G. Filippov
    N. Kubota
    S. Dhadda
    [J]. The Journal of Prevention of Alzheimer's Disease, 2021, 8 : 7 - 18
  • [24] Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial
    Moline, Margaret
    Thein, S.
    Bsharat, M.
    Rabbee, N.
    Kemethofer-Waliczky, M.
    Filippov, G.
    Kubota, N.
    Dhadda, S.
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2021, 8 (01): : 7 - 18
  • [25] ODEVIXIBAT EFFICACY AND SAFETY ACROSS PATIENT SUBGROUPS: AN EVALUATION OF POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 TRIALS
    Sturm, Ekkehard
    Artan, Reha
    Baumann, Ulrich
    Czubkowski, Piotr
    Gupte, Girish
    Durmaz, Ozlem
    Gonzales, Emmanuel M.
    Grammatikopoulos, Tassos
    Kamath, Binita M.
    Lachaux, Alain
    McKiernan, Patrick
    Ozen, Hasan
    D'Antiga, Lorenzo
    Van Der Woerd, Wendy
    Lacaille, Florence
    Rajwal, Sanjay
    Roquelaure, Bertrand
    Soufi, Nisreen
    Shteyer, Eyal
    Tessier, Mary Elizabeth
    Gu, Tao
    Yu, Qifeng
    Stein, Philip
    Clemson, Christine
    Mattsson, Jan P.
    Dalgic, Buket
    [J]. HEPATOLOGY, 2023, 78 : S2104 - S2106
  • [26] Pooled Population Pharmacokinetic Analyses of Venetoclax in Patients Across Indications and Healthy Subjects from Phase 1, 2, and 3 Clinical Trials
    Gong, Jingqi Q. X.
    Suleiman, Ahmed A.
    Menon, Rajeev
    Deng, Rong
    Mensing, Sven
    Salem, Ahmed Hamed
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (08): : 950 - 960
  • [27] Safety profile of tasimelteon, a melatonin MT1 and MT2 receptor agonist: pooled safety analyses from six clinical studies
    Leger, Damien
    Quera-Salva, Maria-Antonia
    Vecchierini, Marie-Francoise
    Ogrizek, Pascale
    Perry, Christina A.
    Dressman, Marlene A.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (11) : 1673 - 1685
  • [28] Insights into the efficacy and safety of tildrakizumab in patients with moderate-to-severe plaque psoriasis across age quartiles: Pooled analyses from the Phase 3 reSURFACE 1 and reSURFACE 2 trials
    Elewski, Boni
    Han, George
    Rozzo, Stephen J.
    Gogineni, Ranga
    Schenkel, Brad
    Guenthner, Scott
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB57 - AB57
  • [29] Efficacy and safety of lebrikizumab at 16 weeks: pooled analyses from ADvocate1 and ADvocate2 phase III trials in patients with moderate-to-severe atopic dermatitis
    Warren, Richard B.
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Thaci, Diamant
    Irvine, Alan
    Gold, Linda Stein
    Blauvelt, Andrew
    Simpson, Eric L.
    Chu, Chia-Yu
    Liu, Zhuqing T.
    Lima, Renata Gontijo
    Pillai, Sreekumar
    Garcia Gil, Esther
    Seneschal, Julien
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [30] Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks
    Haar, Elke L. M. T. E. R.
    Van Den Reek, Juul M. P. A.
    Du Jardin, Kristian Gaarn
    Barbero-castillo, Almudena
    De Jong, Elke M. G. J.
    Lubeek, Satish F. K.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103
12345